BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32490681)

  • 1. HSP90α combined with AFP and TK1 improved the diagnostic value for hepatocellular carcinoma.
    Tang Y; Li K; Cai Z; Xie Y; Tan X; Su C; Li J
    Biomark Med; 2020 Jul; 14(10):869-878. PubMed ID: 32490681
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic value of plasma HSP90α levels for detection of hepatocellular carcinoma.
    Wei W; Liu M; Ning S; Wei J; Zhong J; Li J; Cai Z; Zhang L
    BMC Cancer; 2020 Jan; 20(1):6. PubMed ID: 31898536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Heat Shock Protein 90alpha as a Biomarker for the Diagnosis of Liver Cancer: An Official, Large-scale, and Multicenter Clinical Trial.
    Fu Y; Xu X; Huang D; Cui D; Liu L; Liu J; He Z; Liu J; Zheng S; Luo Y
    EBioMedicine; 2017 Oct; 24():56-63. PubMed ID: 28939487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.
    Nörthen A; Asendorf T; Walson PD; Oellerich M
    Clin Biochem; 2018 Feb; 52():20-25. PubMed ID: 29054441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the diagnostic value of alpha-l-fucosidase, alpha-fetoprotein and thymidine kinase 1 with ROC and logistic regression for hepatocellular carcinoma.
    Zhang SY; Lin BD; Li BR
    FEBS Open Bio; 2015; 5():240-4. PubMed ID: 25870783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.
    Wang Y; Yang H; Xu H; Lu X; Sang X; Zhong S; Huang J; Mao Y
    J Gastroenterol Hepatol; 2014 Mar; 29(3):597-602. PubMed ID: 24236824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma heat shock protein 90alpha as a biomarker for the diagnosis of liver cancer: in patients with different clinicopathologic characteristics.
    Han Y; Zhang Y; Cui L; Li Z; Feng H; Zhang Y; Sun D; Ren L
    World J Surg Oncol; 2021 Aug; 19(1):228. PubMed ID: 34348726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
    Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
    Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis.
    Zhang J; Chen G; Zhang P; Zhang J; Li X; Gan D; Cao X; Han M; Du H; Ye Y
    PLoS One; 2020; 15(2):e0228857. PubMed ID: 32053643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma.
    Welberry C; Macdonald I; McElveen J; Parsy-Kowalska C; Allen J; Healey G; Irving W; Murray A; Chapman C
    PLoS One; 2020; 15(5):e0232247. PubMed ID: 32374744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients.
    Lim TS; Kim DY; Han KH; Kim HS; Shin SH; Jung KS; Kim BK; Kim SU; Park JY; Ahn SH
    Scand J Gastroenterol; 2016 Mar; 51(3):344-53. PubMed ID: 26340708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of glycosylated alpha-fetoprotein improves diagnostic power over the native form in hepatocellular carcinoma.
    Kim H; Kim K; Jin J; Park J; Yu SJ; Yoon JH; Kim Y
    PLoS One; 2014; 9(10):e110366. PubMed ID: 25310463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
    Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
    Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
    World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
    Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.